73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Boys should be given HPV jab, says vaccine committee

Boys should be given HPV jab, says vaccine committee

by Cancer Research UKHuman papillomavirus (HPV) vaccine. Credit:Wikimedia Commons/CC BY-SA 2.0It's nearly a decade since the human papillomavirus (HPV) vaccine was first introduced in t

Boys should be given HPV jab, says vaccine committee

by Cancer Research UKHuman papillomavirus (HPV) vaccine. Credit:Wikimedia Commons/CC BY-SA 2.0It's nearly a decade since the human papillomavirus (HPV) vaccine was first introduced in t
Innovations in cancer treatment through targeted bacterial vaccines

Innovations in cancer treatment through targeted bacterial vaccines

byScience China PressThe schematic illustrates how the nanovaccine induces robust anti-F. nucleatum immune responses that significantly improve the efficiency of chemotherapy and reduce cancer m

Innovations in cancer treatment through targeted bacterial vaccines

byScience China PressThe schematic illustrates how the nanovaccine induces robust anti-F. nucleatum immune responses that significantly improve the efficiency of chemotherapy and reduce cancer m
Race, income can determine blood cancer outcomes, studies show

Race, income can determine blood cancer outcomes, studies show

by Ernie MundellIf someone is stricken with a blood cancer or life-threatening clot, they'll probably fare better if they are white and wealthy, three new studies show.The ongoing impact of patien

Race, income can determine blood cancer outcomes, studies show

by Ernie MundellIf someone is stricken with a blood cancer or life-threatening clot, they'll probably fare better if they are white and wealthy, three new studies show.The ongoing impact of patien
A new combination therapy regimen shows promising results for prostate cancer

A new combination therapy regimen shows promising results for prostate cancer

by Huntsman Cancer InstituteCredit: CC0 Public DomainTALAPRO-2, a study led by Neeraj Agarwal, MD, demonstrated that using TALZENNA, in combination with XTANDI, may reduce the risk of disease progress

A new combination therapy regimen shows promising results for prostate cancer

by Huntsman Cancer InstituteCredit: CC0 Public DomainTALAPRO-2, a study led by Neeraj Agarwal, MD, demonstrated that using TALZENNA, in combination with XTANDI, may reduce the risk of disease progress
Researchers find less risky way to monitor breast cancer progression

Researchers find less risky way to monitor breast cancer progression

by CU Anschutz Medical CampusSchematic for identifying subset of binding sites with TF footprints. (A) When TFs or nucleosomes are bound at TFBSs, they protect different lengths of DNA from nucle

Researchers find less risky way to monitor breast cancer progression

by CU Anschutz Medical CampusSchematic for identifying subset of binding sites with TF footprints. (A) When TFs or nucleosomes are bound at TFBSs, they protect different lengths of DNA from nucle
Computational method used to directly measure tumors shows hypertranscription is ubiquitous across cancers

Computational method used to directly measure tumors shows hypertranscription is ubiquitous across cancers

by Bob Yirka , Medical XpressOverview of RNA output analysis with RNAmp. (A) Hypertranscription occurs when cancer cells elevate their RNA output above normal cell levels (left). Upon RNA extraction f

Computational method used to directly measure tumors shows hypertranscription is ubiquitous across cancers

by Bob Yirka , Medical XpressOverview of RNA output analysis with RNAmp. (A) Hypertranscription occurs when cancer cells elevate their RNA output above normal cell levels (left). Upon RNA extraction f
Novel biomarker for immune checkpoint inhibitors identified in human lethal cancers

Novel biomarker for immune checkpoint inhibitors identified in human lethal cancers

by Liu Jia,Chinese Academy of SciencesA model depicting how the SETD2 inactivation sensitizes cancer cells to immune checkpoint blockade through the NR2F1-STAT1 pathway. Credit: Prof. Wang Yuexi

Novel biomarker for immune checkpoint inhibitors identified in human lethal cancers

by Liu Jia,Chinese Academy of SciencesA model depicting how the SETD2 inactivation sensitizes cancer cells to immune checkpoint blockade through the NR2F1-STAT1 pathway. Credit: Prof. Wang Yuexi
Key insights from statistical modeling of cancer patient life expectancy

Key insights from statistical modeling of cancer patient life expectancy

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainWith the progress in treatment for most cancer types, there is a growing interest to understand the overall impact of a cancer diagnosis t

Key insights from statistical modeling of cancer patient life expectancy

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainWith the progress in treatment for most cancer types, there is a growing interest to understand the overall impact of a cancer diagnosis t
Adding metastasis-directed radiation therapy boosts progression-free survival in metastatic pancreatic cancer

Adding metastasis-directed radiation therapy boosts progression-free survival in metastatic pancreatic cancer

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding metastasis-di

Adding metastasis-directed radiation therapy boosts progression-free survival in metastatic pancreatic cancer

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding metastasis-di
Tumor cells' response to chemotherapy is driven by randomness, shows study

Tumor cells' response to chemotherapy is driven by randomness, shows study

byGarvan Institute of Medical ResearchNeuroblastoma cells (cyan) growing as a tumour and the surrounding collagen matrix (magenta). The cells are expressing a biosensor (JNK-KTR) that reads out

Tumor cells' response to chemotherapy is driven by randomness, shows study

byGarvan Institute of Medical ResearchNeuroblastoma cells (cyan) growing as a tumour and the surrounding collagen matrix (magenta). The cells are expressing a biosensor (JNK-KTR) that reads out
Anti-diabetic drugs could lower risk of primary and secondary brain cancer

Anti-diabetic drugs could lower risk of primary and secondary brain cancer

by University of BristolCredit: CC0 Public DomainDiabetic patients who take anti-diabetic drugs—known as glitazones—long term had a lower risk of primary and secondary brain cancer compared with

Anti-diabetic drugs could lower risk of primary and secondary brain cancer

by University of BristolCredit: CC0 Public DomainDiabetic patients who take anti-diabetic drugs—known as glitazones—long term had a lower risk of primary and secondary brain cancer compared with